Sinus surgery is more effective than antibiotics at treating chronic rhinosinusitis, according to a major clinical trial led by University College London (UCL) along with academics at the University ...
People with allergic fungal rhinosinusitis taking Dupixent (dupilumab) saw significant improvement in congestion and sinus ...
Phase 3 LIBERTY-AIMS results showed dupilumab reduced nasal polyp size and sinus symptoms in adults and children with allergic fungal rhinosinusitis.
Primary endpoint of endoscopic nasal polyp score (NPS) showed reduction of -1.95 (p < 0.0001) in new analysis with adjustment for ...
The results of a pilot study suggest long term exposure to higher pollen levels leads to worse symptoms and quality of life for patients with chronic rhinosinusitis. For the 103 patients ...
Please provide your email address to receive an email when new articles are posted on . At 6 months after randomization, endoscopic sinus surgery patients had significantly reduced SNOT-22 scores vs.
SAN DIEGO -- Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for further treatments, the WAYPOINT trial showed. The monoclonal ...
GSK's Nucala approved in China for CRSwNP, affecting 1/3 of 107 million sinusitis patients; third IL-5 condition indication in the region. Phase 3 trial shows Nucala reduces COPD exacerbations; FDA ...
Add Yahoo as a preferred source to see more of our stories on Google. An Amgen sign is seen at the company's headquarters in Thousand Oaks, California, U.S., November 6, 2019. REUTERS/Deena Beasley By ...
A monthly injection has helped 90% of severe asthma patients reduce daily steroid tablets, which are associated with long-term side effects. More than half of the participants who had received the ...
This image shows a section of sinus tissue with mast cells accumulating in the center (purple). A new study from UC San Diego has found that Veterans with chronic rhinosinusitis from airborne toxins ...
Sinus surgery is more effective than antibiotics at treating chronic rhinosinusitis, according to a major clinical trial led by University College London (UCL) along with academics at the University ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results